Quantcast

Latest Pharmaceuticals policy Stories

2014-08-05 04:21:27

NESS ZIONA, Israel, August 5, 2014 /PRNewswire/ -- Atox Bio today announced that the European Commission has granted AB103 (Sodium acetate salt of the synthetic peptide H-D-Ala-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-D-Ala-OH) orphan medicinal product designation (EU/3/14/1294) for the treatment of necrotizing soft tissue infections. Atox Bio is represented in the EU by Dr. Ulrich Granzer as agent. In addition to a 10-year period of marketing exclusivity in the EU after...

2014-08-04 08:28:51

HAYWARD, Calif., Aug. 4, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) performed a re-inspection of the Company's Hayward, California manufacturing facility from June 16 to July 31, 2014. At the conclusion of the inspection, the FDA issued a Form 483 with seven inspectional observations, two of which are designated as repeat observations. The FDA did not provide any status or classification to these...

2014-08-04 08:28:43

FREDERICK, Md., Aug. 4, 2014 /PRNewswire/ -- The following is a letter from the President of BioElectronics Corporation (OTC Pink: BIEL) to shareholders: Dear BIEL Shareholders: BioElectronics Corporation's mission is to change the way people heal and relieve their pain. As the chart below, that clearly demonstrates that, we have done exactly that. http://photos.prnewswire.com/prnvar/20140801/132705 Chronic pain sufferers in the United Kingdom said that ActiPatch reduced their pain by more...

2014-08-01 23:01:58

MarketOptimizer.org adds “CountryFocus Healthcare, Regulatory and Reimbursement Landscape – Turkey” to its store. The pharmaceutical market was worth approximately $12.5 billion in 2012, and was the sixth-largest pharmaceutical market in Europe. Dallas, Texas (PRWEB) August 01, 2014 Growing prevalence of chronic ailments, medical tourism, universal health coverage and healthcare reforms are boosting healthcare market growth, although a reduction in the price of medicines through...

2014-07-31 20:23:09

2015 Part D Premiums Show Competition, Home Delivery, Choice Deliver Satisfaction and Savings WASHINGTON, July 31, 2014 /PRNewswire-USNewswire/ -- According to data released today by the Centers for Medicare & Medicaid Services, the 2015 average monthly Medicare Part D premium is expected to remain stable at $32, a figure far lower than was originally projected, the Pharmaceutical Care Management Association (PCMA) said. "The popular Part D program continues to be a bright spot...

2014-07-31 16:28:25

ATLANTA, July 31, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Danish Health and Medicines Authority has granted marketing authorization to ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available...

2014-07-31 16:28:08

SARASOTA, Fla., July 31, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced today that it has initiated the development of its lead molecule, Anatabine Citrate, in Europe; and that it has selected Quotient Clinical, The Translational Pharmaceutics Company, based in the United Kingdom (UK) to run its early development programs. http://photos.prnewswire.com/prnvar/20140731/132375 The Company expects to file a Clinical Trial Application (CTA) by the end of...

2014-07-31 16:27:58

Commercial Opportunities and Hurdles Discussed in New Decision Resources Group Executive Briefing BURLINGTON, Mass., July 31, 2014 /PRNewswire/ -- Decision Resources Group's experts are scoping healthcare funding changes brought about by the Affordable Care Act (ACA), which has affected both reimbursement and prescribing of pharmaceutical therapies. The ACA altered how Managed Care Organizations (MCOs) cover beneficiaries through new regulations and expanded access via government-supported...

2014-07-31 12:29:57

As Pharmaceutical Companies Seek to Add Value to Their Products through Patient Support Tools, P&T Committees Show Substantial Interest in Add-Ons BURLINGTON, Mass., July 31, 2014 /PRNewswire/ -- A substantial share of pharmacy and therapeutics (P&T) committee members--who make decisions about which therapies are included in formularies--say patient support resources from pharma influence formulary placement, according to a new Manhattan Research study, Taking the Pulse® Formulary...

2014-07-31 08:37:16

ANTWERP, Belgium and LONDON, July 31, 2014 /PRNewswire/ -- genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the incorporation of genae UK in London. The United Kingdom has one of the largest medical device markets in the world. It was valued at USD 8.9 billion in 2012 and it is projected to increase by a CAGR of 6.0% until 2017. Health expenditure was estimated at USD 234 billion in 2012, equal to...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related